J Cuzick

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

M. Dowsett, Torsten O. Nielsen, Roger A’Hern et al. · JNCI Journal of the National Cancer Institute · 2011 · 2K citations · Full text

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

M Baum, Aman U. Budzar, J Cuzick et al. · The Lancet · 2002 · 2K citations

Breast Oncology, Early Breast Cancer, Medicine +10

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

J Cuzick, JF Forbes, Rob Edwards et al. · The Lancet · 2002 · 742 citations

Breast Oncology, Preventive Medicine, Cancer Screening +10

Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies.

JN Ingle, Mitch Dowsett, J Cuzick et al. · Cancer Research · 2009 · 38 citations

Breast Oncology, Estrogen Receptor, Gynecology +20

Risk of distant recurrence using oncotype DX in postmenopausal primary breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.

Mitch Dowsett, J Cuzick, Craig Wales et al. · Cancer Research · 2009 · 35 citations

Surgical Oncology, Breast Oncology, Recurrence Score +22